News
An interview with Dr. Lisa Carey from the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, NC, panel member on “Use of Immune Checkpoint Inhibitor Pembrolizumab in ...
During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...
A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...
13d
The Brighterside of News on MSNBreakthrough drug could prevent deadly side effect of cancer treatmentImmune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...
Patients with rheumatoid arthritis who undergo immune checkpoint inhibition for metastatic non-small cell lung cancer demonstrate similar overall survival as those without RA, according to data ...
Two studies on checkpoint inhibitors in multiple myeloma presented at the ASH meeting evaluated pembrolizumab in combination with an IMiD. In the multicenter phase 1 KEYNOTE-023 study ...
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to a new global study led by Yale Cancer Center (YCC).
A fatal case of immune checkpoint inhibitor-mediated myasthenia gravis, myositis, and cardiomyopathy overlap syndrome in urothelial carcinoma. Cancer Rep . 2024;7(7):e2140. doi:10.1002/cnr2.2140 ...
Immune checkpoint inhibitors have an established role in the treatment of newly diagnosed metastatic kidney cancer. ... The KEYNOTE-427 study enrolled patients with newly diagnosed mRCC; in that study ...
The optimal second-line treatment for patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors has not been established.
Emerging evidence indicates JAK inhibitors could be a valuable alternative for managing checkpoint inhibitor–induced immune toxicities, especially in difficult-to-treat cases.
Checkpoint inhibitors are really incredible drugs, ... I would be frightened to put a patient with really active GCA on pembrolizumab or say that it’s safe without their disease being controlled.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results